CiplaMed: Your trusted knowledge partner

Hey there! Welcome!

Get updated on

Top Picks

17 Sep, 26

dot

ERS 2026

Key updates on inhalation therapy and nebulization presented at ERS 2026 at Barcelona, Spain from 5th - 9th September, 2026.

16 Sep, 26

dot

ERS 2026

Key updates on Chronic Obstructive Pulmonary Disease (COPD) presented at ERS 2026 at Barcelona, Spain from 5th - 9th September, 2026.

11 Sep, 26

dot

Osteoporos. Int.

In 477,605 individuals (27,942 with T2D), 21,581 major osteoporotic fractures occurred over 1,358,739 person-years
Systemic glucocorticoid use increased fracture risk by 70% versus pre-treatment periods (IRR 1.70)
T2D did not modify glucocorticoid-associated fracture risk (interaction IRR 1.01); findings were consistent across age, sex, and sensitivity analyses.

1 Sep, 26

dot

J Endourol

This nationwide retrospective study of over one million men found that symptomatic benign prostatic hyperplasia (BPH) was associated with a markedly increased risk of kidney stone formation
After propensity score matching, men with BPH were about 2.5 times more likely to develop stones across all age groups
The association may reflect fluid restriction behaviors or shared underlying biological mechanisms.

28 Aug, 26

dot

Chest

Eosinophilic AE-COPD (blood eosinophils ≥300/μL within 3 days before to 1 day after the event), was associated with a significantly lower 1-year risk of major adverse cardiovascular events vs non-eosinophilic AE-COPD
Eosinophilic AE-COPD was linked to reduced risks of heart failure, myocardial infarction, stroke, arrhythmias, and mortality, highlighting eosinophil count as a valuable cardiovascular risk biomarker.

28 Aug, 26

dot

Diabetes Care.

4693 women followed for 10-14 yrs postpartum, showed GDM these subtypes: insulin-deficient (3%), insulin-resistant (9%), mixed-defect (1.6%), & unclassified (0.7%)
Insulin-deficient, insulin-resistant, & mixed-defect GDM were linked to higher risk of prediabetes/diabetes vs no GDM (RR 2.14 to 2.88), metabolic syndrome, & higher predicted CVD risk; dyslipidemia was significant only with insulin-resistant GDM.

7 Sep, 26